616620login-checkDiabetes Drug for Cats Now Approved in Humans Too |
— Oral SGLT2 inhibitor bexagliflozin indicated for adults with type 2 diabetes
The first oral SGLT2 inhibitor approved by the FDA for treating diabetes in cats opens in a new tab or window is now approved for humans with the disease, drugmaker TheracosBios announced.
As an adjunct to diet and exercise, the oral treatment is indicated for adults with type 2 diabetes, and is not recommended for those with type 1 diabetes or for patients in diabetic ketoacidosis, according to the company. Read the full story in Medpage Today.
616620login-checkDiabetes Drug for Cats Now Approved in Humans Too |